Elm Street Ventures


Elm Street Ventures is a seed and early-stage venture fund based in New Haven, Connecticut. Since 2006, the firm has focused on backing Yale faculty engaged in cutting-edge research to address some of the world's largest problems. With Yale as its largest investor, Elm Street Ventures supports teams developing therapeutics, advanced tools, and materials for industry, as well as interventions for climate change. The firm's investment thesis is that great people and great science lead to great impact.

Elm Street Ventures

Elm Street Ventures

33 Whitney Avenue, New Haven, CT 06510


Portfolio

Targeting Cancer with a Novel Protein Degradation Platform

#Biotechnology

Building a Better Future with Green Chemistry. Closed a $9.6 million Series B financing and will build a manufacturing plant in New Haven.

#Green Chemistry

Treating Neurodegenerative Disease by Selectively Blocking the mGluR5 Receptor

#Biotechnology

Targeting Cancer with a Novel RIPTAC “Hold and Kill” Mechanism

#Biotechnology

Leveraging Low-pH Tumor Microenvironments for Selective Targeting

#Biotechnology

Raised $5 million in additional funding to commercialize LED technology developed at Yale University.

#LED Technology


Key People

Managing Partner

Managing Partner

LinkedIn

Venture Partner

Venture Partner